The estimation for the safety and efficacy of ILM blue and membrane bleu dual for retina macular disease

The estimation for the safety and efficacy of ILM blue and membrane bleu dual for retina macular disease - The estimation for efficacy of ILM blue

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032712

Enrollment

200

Registered

2018-05-28

Start date

2012-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy, epiretinal membrane, retinal vein occlusion, macular hole

Interventions

the usage of ILM blue and membrane blue dual

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients undergo the vitrectomy

Exclusion criteria

Exclusion criteria: The cases in which the informed consent were not obtained.

Design outcomes

Primary

Measure	Time frame
visual acuity, retinal thickness, objective findings (retinal bleeding, ischemia, atorophy of optic disc)	—

Countries

Japan

Contacts

Public ContactYoshihiro Takamura

Faculty of Medical Sciences, University of Fukui Department of Ophthalmology

ytakamura@hotmail.com+81-776-61-8403

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026